Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions
Idiopathic Pulmonary Fibrosis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Biosolutions Clinical Research, La Mesa, California, United States
Contact: Principal Investigator (Kaveh Bagheri, MD)University of California San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Jeffrey Golden, MD)Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Contact: Principal Investigator (Augustine Lee, MD)Miami VA Health System, Miami, Florida, United States
Contact: Principal Investigator (Robert Jackson, MD)Northwestern Medicine, Chicago, Illinois, United States
Contact: Principal Investigator (Krishnan Warrior, MD)Indiana University Health, Indianapolis, Indiana, United States
Contact: Principal Investigator (Damien Patel, MD)University of Kansas, Kansas City, Kansas, United States
Contact: Principal Investigator (Mark Hamblin, MD)University of Louisville, Louisville, Kentucky, United States
Contact: Principal Investigator (Mohamed Saad, MD)Beaumont Hospital, Royal Oak, Royal Oak, Michigan, United States
Contact: Principal Investigator (Enrique Calvo-Ayala, MD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Maria Padilla, MD)University of Rochester, Rochester, New York, United States
Contact: Principal Investigator (David Nagel, MD, PhD)UNC Chapel Hill, Chapel Hill, North Carolina, United States
Bend Memorial Hospital, Bend, Oregon, United States
Contact: Principal Investigator (Jeremy Feldman, MD)Temple University Hospital, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Gerard Criner, MD)Avera Research Institute, Sioux Falls, South Dakota, United States
Contact: Principal Investigator (Fady Jamous, MD)Pulmonary & Sleep Specialists, Dickson, Tennessee, United States
Contact: Principal Investigator (Mohammad Alsoub, MD)Baylor University Medical Center, Dallas, Texas, United States
Contact: Principal Investigator (Susan Mathai, MD)Premier Pulmonary Critical Care and Sleep Medicine, Denison, Texas, United States
Contact: Principal Investigator (Sanober Kable, MD)UW Health University Hospital, Madison, Wisconsin, United States
Study leads
Todd Rice, MD, MSc
Principal Investigator
Cumberland Pharmaceuticals